- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03437993
Recollect the Game: A Novel Treatment for Executive Functioning Deficits in Adults With ADHD
Adults who have attention deficit hyperactivity disorder (ADHD) suffer from significant occupational, academic and social problems, many of which are believed to be a result of problems with executive functioning. Executive functioning refers to a group of neuro-psychological functions which include sustained attention, working memory, verbal fluency, as well as motor and mental processing speed. Individuals with ADHD have been shown to have deficits in executive functioning independent of IQ, co-occurring psychiatric disorders, gender, and ADHD subtype. "Recollect" is an application (App) based working memory training video game where participants conduct 3-different adaptive working memory tasks. In each of these tasks participants are presented with a set of stimuli to be remembered while playing a simple platform game where they help navigate an astronaut across the screen and dodge obstacles. Recollect has been designed for all age groups to an interesting, fun and effective brain-training activity. The memory tasks included in the game have been independently shown to improve working memory in a manner that transfers to untrained tasks.
The purpose of this study is to evaluate the effects of playing Recollect versus Tetris for 20 minutes per day, 5 days per week over a 4 week period, on executive functioning deficits in individuals who have Adult ADHD.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Beth Patterson, MSc
- Phone Number: 289-396-4242
- Email: bpatter@mcmaster.ca
Study Contact Backup
- Name: Jasmine Turna, PhD(c)
- Phone Number: 289-396-4242
- Email: turnaj@mcmaster.ca
Study Locations
-
-
Ontario
-
Hamilton, Ontario, Canada, L8S 1B7
- MacAnxiety Research Centre
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Males and females aged 18 and older who own a mobile device such as a Smartphone or tablet.
- Current diagnosis of Adult ADHD, at any stage of treatment.
- Comorbid psychiatric conditions will be allowed.
- Medication or psychotherapy must have been stable (no dose changes) for 4 weeks prior to study participation.
- Must be able to read, write and understand English.
Exclusion Criteria:
- Participant does not own a Smartphone or tablet.
- No dose changes during the 4 week study period.
- No initiation of new psychological therapy or counselling during the 4 week study period.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Recollect
Recollect is a video game which incorporates scientifically supported renditions of N-Back, Item Span, and Multiple-Identity tracking tasks.
These tasks are independently shown to improve working memory in a manner that transfers to untrained tasks.
|
"Recollect" is a working memory training game
|
Sham Comparator: Tetris
Tetris is a video game which has not been shown to have any benefits in the improvement of executive functioning.
|
App-based video game where shapes are rotated and placed to fit a grid
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline on The Behavioral Rating Inventory of Executive Functioning - Adult Version (BRIEF-A)
Time Frame: Change from baseline to week 4
|
It is a validated, clinician-rated scale, measuring executive functioning.
The scale includes 75 items that rates patient symptoms on a 3-point Likert scale (1 = behavior is never observed to 3 = behavior is often observed).
Scores range from 75 to 225: Higher scores indicate greater impairment in executive functioning.
|
Change from baseline to week 4
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline on the Barkley Adult ADHD Rating Scale (BAARS-IV)
Time Frame: Change from baseline to week 4
|
Self-report scale evaluating ADHD symptoms.
Symptom count scores range from 1 to 27, with higher scores indicating more ADHD symptoms.
Total scores range from 27 to 108, with higher scores indicating greater severity of symptoms.
|
Change from baseline to week 4
|
Change from baseline on an App-based neuro-cognitive battery
Time Frame: Change from baseline to week 4
|
A number of neuro-cognitive executive functioning tests, which will be administered via a smartphone application
|
Change from baseline to week 4
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Michael Van Ameringen, MD, FRCPC, McMaster University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Recollect_ADHD
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Adult ADHD
-
University Hospital, Strasbourg, FranceRecruitingAdult ADHD | Adult-onset ADHD With Mood DisorderFrance
-
AstraZenecaCompletedAdult ADHDUnited States
-
University Hospital, Strasbourg, FranceActive, not recruiting
-
University of Maryland, College ParkMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.; Children's National Research InstituteCompleted
-
Karolinska InstitutetRegion StockholmActive, not recruitingParent-Child Relations | Parenting | Child Behavior Problem | Adult ADHDSweden
-
Medical University of South CarolinaShireCompletedAdult Attention Deficit Hyperactivity Disorder (ADHD)United States
-
Okinawa Institute of Science and Technology Graduate...Japan society for the promotion of science; Miyazaki International CollegeRecruiting
-
King's College LondonSouth London and Maudsley NHS Foundation TrustNot yet recruiting
-
Universidad de GranadaNot yet recruiting
Clinical Trials on Recollect, the game
-
Yale UniversityCompleted
-
Xijing HospitalNot yet recruitingAttention Deficit Hyperactivity Disorder
-
University Hospital TuebingenScience Campus Tuebingen; Department of School Psychology, University of TuebingenCompletedObesity | Child
-
University Hospital TuebingenScience Campus TuebingenCompletedObesity | Child
-
Yadigar OrduGazi UniversityCompleted
-
Mayo ClinicCompletedCrohn's Disease | Ulcerative Colitis | Inflammatory Bowel DiseaseUnited States
-
Necmettin Erbakan UniversityNot yet recruitingEducation Nursing
-
Centro Hospitalar de Vila Nova de Gaia/Espinho,...University of MinhoCompleted
-
University GhentKU Leuven; Agentschap voor Innovatie door Wetenschap en TechnologieCompletedNutrition InterventionBelgium
-
Milton S. Hershey Medical CenterUniversity of Kentucky; Hospice Foundation of AmericaRecruitingCommunication | Terminal Illness | Chronic Illness | Advance Care Planning | Advance DirectivesUnited States